-
1
-
-
0028183018
-
International Union of Pharmacology classification of prostanoid receptors: properties, distribution, and structure of the receptors and their subtypes
-
Coleman, R.A., Smith, W.L., Narumiya, S., International Union of Pharmacology classification of prostanoid receptors: properties, distribution, and structure of the receptors and their subtypes. Pharmacol. Rev. 46:2 (1994), 205–229.
-
(1994)
Pharmacol. Rev.
, vol.46
, Issue.2
, pp. 205-229
-
-
Coleman, R.A.1
Smith, W.L.2
Narumiya, S.3
-
2
-
-
0035042253
-
Prostanoid receptors: subtypes and signaling
-
Breyer, R.M., Bagdassarian, C.K., Myers, S.A., Breyer, M.D., Prostanoid receptors: subtypes and signaling. Annu. Rev. Pharmacol. Toxicol. 41 (2001), 661–690.
-
(2001)
Annu. Rev. Pharmacol. Toxicol.
, vol.41
, pp. 661-690
-
-
Breyer, R.M.1
Bagdassarian, C.K.2
Myers, S.A.3
Breyer, M.D.4
-
3
-
-
84959047042
-
Cyclooxygenase 2: its regulation, role and impact in airway inflammation
-
Rumzhum, N.N., Ammit, A.J., Cyclooxygenase 2: its regulation, role and impact in airway inflammation. Clin. Exp. Allergy 46:3 (March 2016), 397–410.
-
(2016)
Clin. Exp. Allergy
, vol.46
, Issue.3
, pp. 397-410
-
-
Rumzhum, N.N.1
Ammit, A.J.2
-
4
-
-
0028356164
-
Molecular cloning and expression of human EP3 receptors: evidence of three variants with differing carboxyl termini
-
Regan, J.W., Bailey, T.J., Donello, J.E., Pierce, K.L., Pepperl, D.J., Zhang, D., Kedzie, K.M., Fairbairn, C.E., Bogardus, A.M., Woodward, D.F., et al. Molecular cloning and expression of human EP3 receptors: evidence of three variants with differing carboxyl termini. Br. J. Pharmacol. 112:2 (1994), 377–385.
-
(1994)
Br. J. Pharmacol.
, vol.112
, Issue.2
, pp. 377-385
-
-
Regan, J.W.1
Bailey, T.J.2
Donello, J.E.3
Pierce, K.L.4
Pepperl, D.J.5
Zhang, D.6
Kedzie, K.M.7
Fairbairn, C.E.8
Bogardus, A.M.9
Woodward, D.F.10
-
5
-
-
0029913957
-
Suppression of prostaglandin E receptor signaling by the variant form of EP1 subtype
-
Okuda-Ashitaka, E., Sakamoto, K., Ezashi, T., Miwa, K., Ito, S., Hayaishi, O., Suppression of prostaglandin E receptor signaling by the variant form of EP1 subtype. J. Biol. Chem. 271:49 (1996), 31255–31261.
-
(1996)
J. Biol. Chem.
, vol.271
, Issue.49
, pp. 31255-31261
-
-
Okuda-Ashitaka, E.1
Sakamoto, K.2
Ezashi, T.3
Miwa, K.4
Ito, S.5
Hayaishi, O.6
-
6
-
-
0027370888
-
Cloning and expression of a cDNA for the human prostaglandin E receptor EP1 subtype
-
Funk, C.D., Furci, L., FitzGerald, G.A., Grygorczyk, R., Rochette, C., Bayne, M.A., Abramovitz, M., Adam, M., Metters, K.M., Cloning and expression of a cDNA for the human prostaglandin E receptor EP1 subtype. J. Biol. Chem. 268:35 (1993), 26767–26772.
-
(1993)
J. Biol. Chem.
, vol.268
, Issue.35
, pp. 26767-26772
-
-
Funk, C.D.1
Furci, L.2
FitzGerald, G.A.3
Grygorczyk, R.4
Rochette, C.5
Bayne, M.A.6
Abramovitz, M.7
Adam, M.8
Metters, K.M.9
-
7
-
-
77952338190
-
EP1 prostanoid receptor coupling to G i/o up-regulates the expression of hypoxia-inducible factor-1 alpha through activation of a phosphoinositide-3 kinase signaling pathway
-
Ji, R., Chou, C.L., Xu, W., Chen, X.B., Woodward, D.F., Regan, J.W., EP1 prostanoid receptor coupling to G i/o up-regulates the expression of hypoxia-inducible factor-1 alpha through activation of a phosphoinositide-3 kinase signaling pathway. Mol. Pharmacol. 77:6 (2010), 1025–1036.
-
(2010)
Mol. Pharmacol.
, vol.77
, Issue.6
, pp. 1025-1036
-
-
Ji, R.1
Chou, C.L.2
Xu, W.3
Chen, X.B.4
Woodward, D.F.5
Regan, J.W.6
-
8
-
-
0027201851
-
Cloning and expression of cDNA for a mouse EP1 subtype of prostaglandin E receptor
-
Watabe, A., Sugimoto, Y., Honda, A., Irie, A., Namba, T., Negishi, M., Ito, S., Narumiya, S., Ichikawa, A., Cloning and expression of cDNA for a mouse EP1 subtype of prostaglandin E receptor. J. Biol. Chem. 268:27 (1993), 20175–20178.
-
(1993)
J. Biol. Chem.
, vol.268
, Issue.27
, pp. 20175-20178
-
-
Watabe, A.1
Sugimoto, Y.2
Honda, A.3
Irie, A.4
Namba, T.5
Negishi, M.6
Ito, S.7
Narumiya, S.8
Ichikawa, A.9
-
9
-
-
0029025507
-
Characterization of the signal transduction of prostaglandin E receptor EP1 subtype in cDNA-transfected Chinese hamster ovary cells
-
Katoh, H., Watabe, A., Sugimoto, Y., Ichikawa, A., Negishi, M., Characterization of the signal transduction of prostaglandin E receptor EP1 subtype in cDNA-transfected Chinese hamster ovary cells. Biochimica. et. biophysica acta 1244:1 (1995), 41–48.
-
(1995)
Biochimica. et. biophysica acta
, vol.1244
, Issue.1
, pp. 41-48
-
-
Katoh, H.1
Watabe, A.2
Sugimoto, Y.3
Ichikawa, A.4
Negishi, M.5
-
10
-
-
0036431951
-
Possible coupling of prostaglandin E receptor EP(1) to TRP5 expressed in Xenopus laevis oocytes
-
Tabata, H., Tanaka, S., Sugimoto, Y., Kanki, H., Kaneko, S., Ichikawa, A., Possible coupling of prostaglandin E receptor EP(1) to TRP5 expressed in Xenopus laevis oocytes. Biochem. Biophys. Res. Commun. 298:3 (2002), 398–402.
-
(2002)
Biochem. Biophys. Res. Commun.
, vol.298
, Issue.3
, pp. 398-402
-
-
Tabata, H.1
Tanaka, S.2
Sugimoto, Y.3
Kanki, H.4
Kaneko, S.5
Ichikawa, A.6
-
11
-
-
0028233402
-
Cloning, functional expression, and characterization of the human prostaglandin E2 receptor EP2 subtype
-
Bastien, L., Sawyer, N., Grygorczyk, R., Metters, K.M., Adam, M., Cloning, functional expression, and characterization of the human prostaglandin E2 receptor EP2 subtype. J. Biol. Chem. 269:16 (1994), 11873–11877.
-
(1994)
J. Biol. Chem.
, vol.269
, Issue.16
, pp. 11873-11877
-
-
Bastien, L.1
Sawyer, N.2
Grygorczyk, R.3
Metters, K.M.4
Adam, M.5
-
12
-
-
0027998445
-
Cloning of a novel human prostaglandin receptor with characteristics of the pharmacologically defined EP2 subtype
-
Regan, J.W., Bailey, T.J., Pepperl, D.J., Pierce, K.L., Bogardus, A.M., Donello, J.E., Fairbairn, C.E., Kedzie, K.M., Woodward, D.F., Gil, D.W., Cloning of a novel human prostaglandin receptor with characteristics of the pharmacologically defined EP2 subtype. Mol. Pharmacol. 46:2 (1994), 213–220.
-
(1994)
Mol. Pharmacol.
, vol.46
, Issue.2
, pp. 213-220
-
-
Regan, J.W.1
Bailey, T.J.2
Pepperl, D.J.3
Pierce, K.L.4
Bogardus, A.M.5
Donello, J.E.6
Fairbairn, C.E.7
Kedzie, K.M.8
Woodward, D.F.9
Gil, D.W.10
-
13
-
-
0028351836
-
A novel inhibitory prostanoid receptor in piglet saphenous vein
-
Coleman, R.A., Grix, S.P., Head, S.A., Louttit, J.B., Mallett, A., Sheldrick, R.L., A novel inhibitory prostanoid receptor in piglet saphenous vein. Prostaglandins 47:2 (1994), 151–168.
-
(1994)
Prostaglandins
, vol.47
, Issue.2
, pp. 151-168
-
-
Coleman, R.A.1
Grix, S.P.2
Head, S.A.3
Louttit, J.B.4
Mallett, A.5
Sheldrick, R.L.6
-
14
-
-
0029037548
-
Identification of prostaglandin E receptor 'EP2' cloned from mastocytoma cells EP4 subtype
-
Nishigaki, N., Negishi, M., Honda, A., Sugimoto, Y., Namba, T., Narumiya, S., Ichikawa, A., Identification of prostaglandin E receptor 'EP2' cloned from mastocytoma cells EP4 subtype. FEBS Lett. 364:3 (1995), 339–341.
-
(1995)
FEBS Lett.
, vol.364
, Issue.3
, pp. 339-341
-
-
Nishigaki, N.1
Negishi, M.2
Honda, A.3
Sugimoto, Y.4
Namba, T.5
Narumiya, S.6
Ichikawa, A.7
-
15
-
-
0030871070
-
Ligand binding specificities of the eight types and subtypes of the mouse prostanoid receptors expressed in Chinese hamster ovary cells
-
Kiriyama, M., Ushikubi, F., Kobayashi, T., Hirata, M., Sugimoto, Y., Narumiya, S., Ligand binding specificities of the eight types and subtypes of the mouse prostanoid receptors expressed in Chinese hamster ovary cells. Br. J. Pharmacol. 122:2 (1997), 217–224.
-
(1997)
Br. J. Pharmacol.
, vol.122
, Issue.2
, pp. 217-224
-
-
Kiriyama, M.1
Ushikubi, F.2
Kobayashi, T.3
Hirata, M.4
Sugimoto, Y.5
Narumiya, S.6
-
16
-
-
0242321274
-
EP2 and EP4 prostanoid receptor signaling
-
Regan, J.W., EP2 and EP4 prostanoid receptor signaling. Life Sci. 74:2–3 (2003), 143–153.
-
(2003)
Life Sci.
, vol.74
, Issue.2-3
, pp. 143-153
-
-
Regan, J.W.1
-
17
-
-
0028915988
-
Molecular evolution of receptors for eicosanoids
-
Toh, H., Ichikawa, A., Narumiya, S., Molecular evolution of receptors for eicosanoids. FEBS Lett. 361:1 (1995), 17–21.
-
(1995)
FEBS Lett.
, vol.361
, Issue.1
, pp. 17-21
-
-
Toh, H.1
Ichikawa, A.2
Narumiya, S.3
-
18
-
-
84859884891
-
Novel cAMP signalling paradigms: therapeutic implications for airway disease
-
Billington, C.K., Hall, I.P., Novel cAMP signalling paradigms: therapeutic implications for airway disease. Br. J. Pharmacol. 166:2 (2012), 401–410.
-
(2012)
Br. J. Pharmacol.
, vol.166
, Issue.2
, pp. 401-410
-
-
Billington, C.K.1
Hall, I.P.2
-
19
-
-
0032823306
-
Prostanoid receptors: structures, properties, and functions
-
Narumiya, S., Sugimoto, Y., Ushikubi, F., Prostanoid receptors: structures, properties, and functions. Physiol. Rev. 79:4 (1999), 1193–1226.
-
(1999)
Physiol. Rev.
, vol.79
, Issue.4
, pp. 1193-1226
-
-
Narumiya, S.1
Sugimoto, Y.2
Ushikubi, F.3
-
20
-
-
0033664001
-
Comparison of agonist-induced internalization of the human EP2 and EP4 prostaglandin receptors: role of the carboxyl terminus in EP4 receptor sequestration
-
Desai, S., April, H., Nwaneshiudu, C., Ashby, B., Comparison of agonist-induced internalization of the human EP2 and EP4 prostaglandin receptors: role of the carboxyl terminus in EP4 receptor sequestration. Mol. Pharmacol. 58:6 (2000), 1279–1286.
-
(2000)
Mol. Pharmacol.
, vol.58
, Issue.6
, pp. 1279-1286
-
-
Desai, S.1
April, H.2
Nwaneshiudu, C.3
Ashby, B.4
-
21
-
-
0029661961
-
Two Gs-coupled prostaglandin E receptor subtypes, EP2 and EP4, differ in desensitization and sensitivity to the metabolic inactivation of the agonist
-
Nishigaki, N., Negishi, M., Ichikawa, A., Two Gs-coupled prostaglandin E receptor subtypes, EP2 and EP4, differ in desensitization and sensitivity to the metabolic inactivation of the agonist. Mol. Pharmacol. 50:4 (1996), 1031–1037.
-
(1996)
Mol. Pharmacol.
, vol.50
, Issue.4
, pp. 1031-1037
-
-
Nishigaki, N.1
Negishi, M.2
Ichikawa, A.3
-
22
-
-
0037169557
-
Phosphorylation of glycogen synthase kinase-3 and stimulation of T-cell factor signaling following activation of EP2 and EP4 prostanoid receptors by prostaglandin E2
-
Fujino, H., West, K.A., Regan, J.W., Phosphorylation of glycogen synthase kinase-3 and stimulation of T-cell factor signaling following activation of EP2 and EP4 prostanoid receptors by prostaglandin E2. J. Biol. Chem. 277:4 (2002), 2614–2619.
-
(2002)
J. Biol. Chem.
, vol.277
, Issue.4
, pp. 2614-2619
-
-
Fujino, H.1
West, K.A.2
Regan, J.W.3
-
23
-
-
33644848353
-
EP(4) prostanoid receptor coupling to a pertussis toxin-sensitive inhibitory G protein
-
Fujino, H., Regan, J.W., EP(4) prostanoid receptor coupling to a pertussis toxin-sensitive inhibitory G protein. Mol. Pharmacol. 69:1 (2006), 5–10.
-
(2006)
Mol. Pharmacol.
, vol.69
, Issue.1
, pp. 5-10
-
-
Fujino, H.1
Regan, J.W.2
-
24
-
-
0032518695
-
Signal transduction by the Wnt family of ligands
-
Dale, T.C., Signal transduction by the Wnt family of ligands. Biochem. J. 329:Pt 2 (1998), 209–223.
-
(1998)
Biochem. J.
, vol.329
, pp. 209-223
-
-
Dale, T.C.1
-
25
-
-
0034053069
-
Wnt signaling in oncogenesis and embryogenesis–a look outside the nucleus
-
Peifer, M., Polakis, P., Wnt signaling in oncogenesis and embryogenesis–a look outside the nucleus. Science 287:5458 (2000), 1606–1609.
-
(2000)
Science
, vol.287
, Issue.5458
, pp. 1606-1609
-
-
Peifer, M.1
Polakis, P.2
-
26
-
-
0042734625
-
Prostanoid receptors and phosphatidylinositol 3-kinase: a pathway to cancer?
-
Fujino, H., Regan, J.W., Prostanoid receptors and phosphatidylinositol 3-kinase: a pathway to cancer?. Trends Pharmacol. Sci. 24:7 (2003), 335–340.
-
(2003)
Trends Pharmacol. Sci.
, vol.24
, Issue.7
, pp. 335-340
-
-
Fujino, H.1
Regan, J.W.2
-
27
-
-
0030911052
-
Role of phosphoinositide 3-OH kinase in cell transformation and control of the actin cytoskeleton by Ras
-
Rodriguez-Viciana, P., Warne, P.H., Khwaja, A., Marte, B.M., Pappin, D., Das, P., Waterfield, M.D., Ridley, A., Downward, J., Role of phosphoinositide 3-OH kinase in cell transformation and control of the actin cytoskeleton by Ras. Cell 89:3 (1997), 457–467.
-
(1997)
Cell
, vol.89
, Issue.3
, pp. 457-467
-
-
Rodriguez-Viciana, P.1
Warne, P.H.2
Khwaja, A.3
Marte, B.M.4
Pappin, D.5
Das, P.6
Waterfield, M.D.7
Ridley, A.8
Downward, J.9
-
28
-
-
0035375104
-
Agonist-dependent recruitment of phosphoinositide 3-kinase to the membrane by beta-adrenergic receptor kinase 1. A role in receptor sequestration
-
Naga Prasad, S.V., Barak, L.S., Rapacciuolo, A., Caron, M.G., Rockman, H.A., Agonist-dependent recruitment of phosphoinositide 3-kinase to the membrane by beta-adrenergic receptor kinase 1. A role in receptor sequestration. J. Biol. Chem. 276:22 (2001), 18953–18959.
-
(2001)
J. Biol. Chem.
, vol.276
, Issue.22
, pp. 18953-18959
-
-
Naga Prasad, S.V.1
Barak, L.S.2
Rapacciuolo, A.3
Caron, M.G.4
Rockman, H.A.5
-
29
-
-
4444280871
-
What turns CREB on?
-
Johannessen, M., Delghandi, M.P., Moens, U., What turns CREB on?. Cell Signal 16:11 (2004), 1211–1227.
-
(2004)
Cell Signal
, vol.16
, Issue.11
, pp. 1211-1227
-
-
Johannessen, M.1
Delghandi, M.P.2
Moens, U.3
-
30
-
-
0035430282
-
Transcriptional regulation by the phosphorylation-dependent factor CREB
-
Mayr, B., Montminy, M., Transcriptional regulation by the phosphorylation-dependent factor CREB. Nat. Rev. Mol. Cell Biol. 2:8 (2001), 599–609.
-
(2001)
Nat. Rev. Mol. Cell Biol.
, vol.2
, Issue.8
, pp. 599-609
-
-
Mayr, B.1
Montminy, M.2
-
31
-
-
22344439814
-
Differential regulation of phosphorylation of the cAMP response element-binding protein after activation of EP2 and EP4 prostanoid receptors by prostaglandin E2
-
Fujino, H., Salvi, S., Regan, J.W., Differential regulation of phosphorylation of the cAMP response element-binding protein after activation of EP2 and EP4 prostanoid receptors by prostaglandin E2. Mol. Pharmacol. 68:1 (2005), 251–259.
-
(2005)
Mol. Pharmacol.
, vol.68
, Issue.1
, pp. 251-259
-
-
Fujino, H.1
Salvi, S.2
Regan, J.W.3
-
32
-
-
13444282669
-
E-ring 8-isoprostanes are agonists at EP2- and EP4-prostanoid receptors on human airway smooth muscle cells and regulate the release of colony-stimulating factors by activating cAMP-dependent protein kinase
-
Clarke, D.L., Belvisi, M.G., Hardaker, E., Newton, R., Giembycz, M.A., E-ring 8-isoprostanes are agonists at EP2- and EP4-prostanoid receptors on human airway smooth muscle cells and regulate the release of colony-stimulating factors by activating cAMP-dependent protein kinase. Mol. Pharmaco. 67:2 (2005), 383–393.
-
(2005)
Mol. Pharmaco.
, vol.67
, Issue.2
, pp. 383-393
-
-
Clarke, D.L.1
Belvisi, M.G.2
Hardaker, E.3
Newton, R.4
Giembycz, M.A.5
-
33
-
-
0036594073
-
Prostaglandin receptors: advances in the study of EP3 receptor signaling
-
Hatae, N., Sugimoto, Y., Ichikawa, A., Prostaglandin receptors: advances in the study of EP3 receptor signaling. J. Biochem. 131:6 (2002), 781–784.
-
(2002)
J. Biochem.
, vol.131
, Issue.6
, pp. 781-784
-
-
Hatae, N.1
Sugimoto, Y.2
Ichikawa, A.3
-
34
-
-
0032945685
-
Prostaglandin E-prostanoid-3 receptor activation of cyclic AMP response element-mediated gene transcription
-
Audoly, L.P., Ma, L., Feoktistov, I., de Foe, S.K., Breyer, M.D., Breyer, R.M., Prostaglandin E-prostanoid-3 receptor activation of cyclic AMP response element-mediated gene transcription. J. Pharmacol. Exp. Ther. 289:1 (1999), 140–148.
-
(1999)
J. Pharmacol. Exp. Ther.
, vol.289
, Issue.1
, pp. 140-148
-
-
Audoly, L.P.1
Ma, L.2
Feoktistov, I.3
de Foe, S.K.4
Breyer, M.D.5
Breyer, R.M.6
-
35
-
-
62249100641
-
EP(3) prostanoid receptor isoforms utilize distinct mechanisms to regulate ERK 1/2 activation
-
Israel, D.D., Regan, J.W., EP(3) prostanoid receptor isoforms utilize distinct mechanisms to regulate ERK 1/2 activation. Biochimica et biophysica acta 1791:4 (2009), 238–245.
-
(2009)
Biochimica et biophysica acta
, vol.1791
, Issue.4
, pp. 238-245
-
-
Israel, D.D.1
Regan, J.W.2
-
36
-
-
17744382792
-
Multiple signal transduction pathways through two prostaglandin E receptor EP3 subtype isoforms expressed in human uterus
-
Kotani, M., Tanaka, I., Ogawa, Y., Suganami, T., Matsumoto, T., Muro, S., Yamamoto, Y., Sugawara, A., Yoshimasa, Y., Sagawa, N., Narumiya, S., Nakao, K., Multiple signal transduction pathways through two prostaglandin E receptor EP3 subtype isoforms expressed in human uterus. J. Clin. Endocrinol. Metab. 85:11 (2000), 4315–4322.
-
(2000)
J. Clin. Endocrinol. Metab.
, vol.85
, Issue.11
, pp. 4315-4322
-
-
Kotani, M.1
Tanaka, I.2
Ogawa, Y.3
Suganami, T.4
Matsumoto, T.5
Muro, S.6
Yamamoto, Y.7
Sugawara, A.8
Yoshimasa, Y.9
Sagawa, N.10
Narumiya, S.11
Nakao, K.12
-
37
-
-
4143144369
-
Human prostaglandin EP3 receptor isoforms show different agonist-induced internalization patterns
-
Bilson, H.A., Mitchell, D.L., Ashby, B., Human prostaglandin EP3 receptor isoforms show different agonist-induced internalization patterns. FEBS Lett. 572:1–3 (2004), 271–275.
-
(2004)
FEBS Lett.
, vol.572
, Issue.1-3
, pp. 271-275
-
-
Bilson, H.A.1
Mitchell, D.L.2
Ashby, B.3
-
38
-
-
0031569412
-
Structural organization of the human prostaglandin EP3 receptor subtype gene (PTGER3)
-
Kotani, M., Tanaka, I., Ogawa, Y., Usui, T., Tamura, N., Mori, K., Narumiya, S., Yoshimi, T., Nakao, K., Structural organization of the human prostaglandin EP3 receptor subtype gene (PTGER3). Genomics 40:3 (1997), 425–434.
-
(1997)
Genomics
, vol.40
, Issue.3
, pp. 425-434
-
-
Kotani, M.1
Tanaka, I.2
Ogawa, Y.3
Usui, T.4
Tamura, N.5
Mori, K.6
Narumiya, S.7
Yoshimi, T.8
Nakao, K.9
-
39
-
-
0028809229
-
Splice variants of the human EP3 receptor for prostaglandin E2
-
Schmid, A., Thierauch, K.H., Schleuning, W.D., Dinter, H., Splice variants of the human EP3 receptor for prostaglandin E2. Eur. J. Biochem. 228:1 (1995), 23–30.
-
(1995)
Eur. J. Biochem.
, vol.228
, Issue.1
, pp. 23-30
-
-
Schmid, A.1
Thierauch, K.H.2
Schleuning, W.D.3
Dinter, H.4
-
40
-
-
0030999720
-
Constitutive activity of human prostaglandin E receptor EP3 isoforms
-
Jin, J., Mao, G.F., Ashby, B., Constitutive activity of human prostaglandin E receptor EP3 isoforms. Br. J. Pharmacol. 121:2 (1997), 317–323.
-
(1997)
Br. J. Pharmacol.
, vol.121
, Issue.2
, pp. 317-323
-
-
Jin, J.1
Mao, G.F.2
Ashby, B.3
-
41
-
-
33645848172
-
Evaluation of selective prostaglandin E2 (PGE2) receptor agonists as therapeutic agents for the treatment of asthma
-
pe47
-
Chung, K.F., Evaluation of selective prostaglandin E2 (PGE2) receptor agonists as therapeutic agents for the treatment of asthma. Sci. STKE 2005, 303, 2005 pe47.
-
(2005)
Sci. STKE 2005
, vol.303
-
-
Chung, K.F.1
-
42
-
-
0029056741
-
Activation of mitogen-activated protein kinase by the human prostaglandin EP3A receptor
-
Burkey, T.H., Regan, J.W., Activation of mitogen-activated protein kinase by the human prostaglandin EP3A receptor. Biochem. Biophys. Res. Commun. 211:1 (1995), 152–158.
-
(1995)
Biochem. Biophys. Res. Commun.
, vol.211
, Issue.1
, pp. 152-158
-
-
Burkey, T.H.1
Regan, J.W.2
-
43
-
-
28444491736
-
The EP3 receptor stimulates ceramide and diacylglycerol release and inhibits growth of primary keratinocytes
-
Konger, R.L., Brouxhon, S., Partillo, S., VanBuskirk, J., Pentland, A.P., The EP3 receptor stimulates ceramide and diacylglycerol release and inhibits growth of primary keratinocytes. Exp. Dermatol. 14:12 (2005), 914–922.
-
(2005)
Exp. Dermatol.
, vol.14
, Issue.12
, pp. 914-922
-
-
Konger, R.L.1
Brouxhon, S.2
Partillo, S.3
VanBuskirk, J.4
Pentland, A.P.5
-
44
-
-
5444265539
-
Vasoconstriction induced by activation of EP1 and EP3 receptors in human lung: effects of ONO-AE-248, ONO-DI-004, ONO-8711 or ONO-8713
-
Norel, X., de Montpreville, V., Brink, C., Vasoconstriction induced by activation of EP1 and EP3 receptors in human lung: effects of ONO-AE-248, ONO-DI-004, ONO-8711 or ONO-8713. Prostaglandins Other Lipid Mediat. 74:1–4 (2004), 101–112.
-
(2004)
Prostaglandins Other Lipid Mediat.
, vol.74
, Issue.1-4
, pp. 101-112
-
-
Norel, X.1
de Montpreville, V.2
Brink, C.3
-
45
-
-
0034455647
-
The role of prostaglandin E receptor subtypes (EP1, EP2, EP3, and EP4) in bone resorption: an analysis using specific agonists for the respective EPs
-
Suzawa, T., Miyaura, C., Inada, M., Maruyama, T., Sugimoto, Y., Ushikubi, F., Ichikawa, A., Narumiya, S., Suda, T., The role of prostaglandin E receptor subtypes (EP1, EP2, EP3, and EP4) in bone resorption: an analysis using specific agonists for the respective EPs. Endocrinology 141:4 (2000), 1554–1559.
-
(2000)
Endocrinology
, vol.141
, Issue.4
, pp. 1554-1559
-
-
Suzawa, T.1
Miyaura, C.2
Inada, M.3
Maruyama, T.4
Sugimoto, Y.5
Ushikubi, F.6
Ichikawa, A.7
Narumiya, S.8
Suda, T.9
-
46
-
-
0032698210
-
Role of the prostaglandin E receptor subtype EP1 in colon carcinogenesis
-
Watanabe, K., Kawamori, T., Nakatsugi, S., Ohta, T., Ohuchida, S., Yamamoto, H., Maruyama, T., Kondo, K., Ushikubi, F., Narumiya, S., Sugimura, T., Wakabayashi, K., Role of the prostaglandin E receptor subtype EP1 in colon carcinogenesis. Cancer Res. 59:20 (1999), 5093–5096.
-
(1999)
Cancer Res.
, vol.59
, Issue.20
, pp. 5093-5096
-
-
Watanabe, K.1
Kawamori, T.2
Nakatsugi, S.3
Ohta, T.4
Ohuchida, S.5
Yamamoto, H.6
Maruyama, T.7
Kondo, K.8
Ushikubi, F.9
Narumiya, S.10
Sugimura, T.11
Wakabayashi, K.12
-
47
-
-
18744435476
-
Inhibitory effect of a prostaglandin E receptor subtype EP(1) selective antagonist, ONO-8713, on development of azoxymethane-induced aberrant crypt foci in mice
-
Watanabe, K., Kawamori, T., Nakatsugi, S., Ohta, T., Ohuchida, S., Yamamoto, H., Maruyama, T., Kondo, K., Narumiya, S., Sugimura, T., Wakabayashi, K., Inhibitory effect of a prostaglandin E receptor subtype EP(1) selective antagonist, ONO-8713, on development of azoxymethane-induced aberrant crypt foci in mice. Cancer Lett. 156:1 (2000), 57–61.
-
(2000)
Cancer Lett.
, vol.156
, Issue.1
, pp. 57-61
-
-
Watanabe, K.1
Kawamori, T.2
Nakatsugi, S.3
Ohta, T.4
Ohuchida, S.5
Yamamoto, H.6
Maruyama, T.7
Kondo, K.8
Narumiya, S.9
Sugimura, T.10
Wakabayashi, K.11
-
48
-
-
33846136755
-
The discovery of 6-[2-(5-chloro-2-{[(2,4-difluorophenyl)methyl]oxy}phenyl)-1-cyclopenten-1-yl]-2-p yridinecarboxylic acid, GW848687X, a potent and selective prostaglandin EP1 receptor antagonist for the treatment of inflammatory pain
-
Giblin, G.M., Bit, R.A., Brown, S.H., Chaignot, H.M., Chowdhury, A., Chessell, I.P., Clayton, N.M., Coleman, T., Hall, A., Hammond, B., Hurst, D.N., Michel, A.D., Naylor, A., Novelli, R., Scoccitti, T., Spalding, D., Tang, S.P., Wilson, A.W., Wilson, R., The discovery of 6-[2-(5-chloro-2-{[(2,4-difluorophenyl)methyl]oxy}phenyl)-1-cyclopenten-1-yl]-2-p yridinecarboxylic acid, GW848687X, a potent and selective prostaglandin EP1 receptor antagonist for the treatment of inflammatory pain. Bioorg. Med. Chem. Lett. 17:2 (2007), 385–389.
-
(2007)
Bioorg. Med. Chem. Lett.
, vol.17
, Issue.2
, pp. 385-389
-
-
Giblin, G.M.1
Bit, R.A.2
Brown, S.H.3
Chaignot, H.M.4
Chowdhury, A.5
Chessell, I.P.6
Clayton, N.M.7
Coleman, T.8
Hall, A.9
Hammond, B.10
Hurst, D.N.11
Michel, A.D.12
Naylor, A.13
Novelli, R.14
Scoccitti, T.15
Spalding, D.16
Tang, S.P.17
Wilson, A.W.18
Wilson, R.19
-
49
-
-
0027424447
-
N-substituted dibenzoxazepines as analgesic PGE2 antagonists
-
Hallinan, E.A., Hagen, T.J., Husa, R.K., Tsymbalov, S., Rao, S.N., vanHoeck, J.P., Rafferty, M.F., Stapelfeld, A., Savage, M.A., Reichman, M., N-substituted dibenzoxazepines as analgesic PGE2 antagonists. J. Med. Chem. 36:22 (1993), 3293–3299.
-
(1993)
J. Med. Chem.
, vol.36
, Issue.22
, pp. 3293-3299
-
-
Hallinan, E.A.1
Hagen, T.J.2
Husa, R.K.3
Tsymbalov, S.4
Rao, S.N.5
vanHoeck, J.P.6
Rafferty, M.F.7
Stapelfeld, A.8
Savage, M.A.9
Reichman, M.10
-
50
-
-
0034633263
-
A reporter gene assay for high-throughput screening of G-protein-coupled receptors stably or transiently expressed in HEK293 EBNA cells grown in suspension culture
-
Durocher, Y., Perret, S., Thibaudeau, E., Gaumond, M.H., Kamen, A., Stocco, R., Abramovitz, M., A reporter gene assay for high-throughput screening of G-protein-coupled receptors stably or transiently expressed in HEK293 EBNA cells grown in suspension culture. Anal Biochem. 284:2 (2000), 316–326.
-
(2000)
Anal Biochem.
, vol.284
, Issue.2
, pp. 316-326
-
-
Durocher, Y.1
Perret, S.2
Thibaudeau, E.3
Gaumond, M.H.4
Kamen, A.5
Stocco, R.6
Abramovitz, M.7
-
51
-
-
0033971515
-
The utilization of recombinant prostanoid receptors to determine the affinities and selectivities of prostaglandins and related analogs
-
Abramovitz, M., Adam, M., Boie, Y., Carriere, M., Denis, D., Godbout, C., Lamontagne, S., Rochette, C., Sawyer, N., Tremblay, N.M., Belley, M., Gallant, M., Dufresne, C., Gareau, Y., Ruel, R., Juteau, H., Labelle, M., Ouimet, N., Metters, K.M., The utilization of recombinant prostanoid receptors to determine the affinities and selectivities of prostaglandins and related analogs. Biochimica et biophysica acta 1483:2 (2000), 285–293.
-
(2000)
Biochimica et biophysica acta
, vol.1483
, Issue.2
, pp. 285-293
-
-
Abramovitz, M.1
Adam, M.2
Boie, Y.3
Carriere, M.4
Denis, D.5
Godbout, C.6
Lamontagne, S.7
Rochette, C.8
Sawyer, N.9
Tremblay, N.M.10
Belley, M.11
Gallant, M.12
Dufresne, C.13
Gareau, Y.14
Ruel, R.15
Juteau, H.16
Labelle, M.17
Ouimet, N.18
Metters, K.M.19
-
52
-
-
33744549867
-
Investigation of the pronounced synergism between prostaglandin E2 and other constrictor agents on rat femoral artery
-
Hung, G.H., Jones, R.L., Lam, F.F., Chan, K.M., Hidaka, H., Suzuki, M., Sasaki, Y., Investigation of the pronounced synergism between prostaglandin E2 and other constrictor agents on rat femoral artery. Prostaglandins Leukot Essent Fatty Acids 74:6 (2006), 401–415.
-
(2006)
Prostaglandins Leukot Essent Fatty Acids
, vol.74
, Issue.6
, pp. 401-415
-
-
Hung, G.H.1
Jones, R.L.2
Lam, F.F.3
Chan, K.M.4
Hidaka, H.5
Suzuki, M.6
Sasaki, Y.7
-
53
-
-
0015245283
-
Prostaglandin inhibition with a dibenzoxazepine hydrazide derivative and morphine
-
Sanner, J., Prostaglandin inhibition with a dibenzoxazepine hydrazide derivative and morphine. Ann. N. Y. Acad. Sci. 180 (1971), 396–409.
-
(1971)
Ann. N. Y. Acad. Sci.
, vol.180
, pp. 396-409
-
-
Sanner, J.1
-
54
-
-
0021261354
-
Antagonistic effect of SC-19220 on the responses of Guinea-pig gastric muscles to prostaglandins E1, E2 and F2 alpha
-
Rakovska, A., Milenov, K., Antagonistic effect of SC-19220 on the responses of Guinea-pig gastric muscles to prostaglandins E1, E2 and F2 alpha. Arch. Int. Pharmacodyn. Ther. 268:1 (1984), 59–69.
-
(1984)
Arch. Int. Pharmacodyn. Ther.
, vol.268
, Issue.1
, pp. 59-69
-
-
Rakovska, A.1
Milenov, K.2
-
55
-
-
0021978802
-
Characterisation of the prostanoid receptors mediating contraction of Guinea-pig isolated trachea
-
Coleman, R.A., Kennedy, I., Characterisation of the prostanoid receptors mediating contraction of Guinea-pig isolated trachea. Prostaglandins 29:3 (1985), 363–375.
-
(1985)
Prostaglandins
, vol.29
, Issue.3
, pp. 363-375
-
-
Coleman, R.A.1
Kennedy, I.2
-
56
-
-
4644332929
-
Functional pharmacology of human prostanoid EP2 and EP4 receptors
-
Wilson, R.J., Rhodes, S.A., Wood, R.L., Shield, V.J., Noel, L.S., Gray, D.W., Giles, H., Functional pharmacology of human prostanoid EP2 and EP4 receptors. Euro. J. Pharmacol. 501:1–3 (2004), 49–58.
-
(2004)
Euro. J. Pharmacol.
, vol.501
, Issue.1-3
, pp. 49-58
-
-
Wilson, R.J.1
Rhodes, S.A.2
Wood, R.L.3
Shield, V.J.4
Noel, L.S.5
Gray, D.W.6
Giles, H.7
-
57
-
-
0035817369
-
Design and synthesis of a highly selective EP2-receptor agonist
-
Tani, K., Naganawa, A., Ishida, A., Egashira, H., Sagawa, K., Harada, H., Ogawa, M., Maruyama, T., Ohuchida, S., Nakai, H., Kondo, K., Toda, M., Design and synthesis of a highly selective EP2-receptor agonist. Bioorg. Med. Chem. Lett. 11:15 (2001), 2025–2028.
-
(2001)
Bioorg. Med. Chem. Lett.
, vol.11
, Issue.15
, pp. 2025-2028
-
-
Tani, K.1
Naganawa, A.2
Ishida, A.3
Egashira, H.4
Sagawa, K.5
Harada, H.6
Ogawa, M.7
Maruyama, T.8
Ohuchida, S.9
Nakai, H.10
Kondo, K.11
Toda, M.12
-
58
-
-
18244408594
-
Development of a highly selective EP2-receptor agonist. Part 1: identification of 16-hydroxy-17,17-trimethylene PGE2 derivatives
-
Tani, K., Naganawa, A., Ishida, A., Sagawa, K., Harada, H., Ogawa, M., Maruyama, T., Ohuchida, S., Nakai, H., Kondo, K., Toda, M., Development of a highly selective EP2-receptor agonist. Part 1: identification of 16-hydroxy-17,17-trimethylene PGE2 derivatives. Bioorg. Med. Chem. 10:4 (2002), 1093–1106.
-
(2002)
Bioorg. Med. Chem.
, vol.10
, Issue.4
, pp. 1093-1106
-
-
Tani, K.1
Naganawa, A.2
Ishida, A.3
Sagawa, K.4
Harada, H.5
Ogawa, M.6
Maruyama, T.7
Ohuchida, S.8
Nakai, H.9
Kondo, K.10
Toda, M.11
-
59
-
-
84901264631
-
Prostanoid receptor EP2 as a therapeutic target
-
Ganesh, T., Prostanoid receptor EP2 as a therapeutic target. J. Med. Chem. 57:11 (2014), 4454–4465.
-
(2014)
J. Med. Chem.
, vol.57
, Issue.11
, pp. 4454-4465
-
-
Ganesh, T.1
-
60
-
-
84874831860
-
Differential regulation of airway smooth muscle cell migration by E-prostanoid receptor subtypes
-
Aso, H., Ito, S., Mori, A., Suganuma, N., Morioka, M., Takahara, N., Kondo, M., Hasegawa, Y., Differential regulation of airway smooth muscle cell migration by E-prostanoid receptor subtypes. Am. J. Resp. Cell Mol. Biol. 48:3 (2013), 322–329.
-
(2013)
Am. J. Resp. Cell Mol. Biol.
, vol.48
, Issue.3
, pp. 322-329
-
-
Aso, H.1
Ito, S.2
Mori, A.3
Suganuma, N.4
Morioka, M.5
Takahara, N.6
Kondo, M.7
Hasegawa, Y.8
-
61
-
-
0027504995
-
AH13205, a selective prostanoid EP2-receptor agonist
-
Nials, A.T., Vardey, C.J., Denyer, L.H., Thomas, M., Sparrow, S.J., Shepherd, G.D., Coleman, R.A., AH13205, a selective prostanoid EP2-receptor agonist. Cardiovas. Drug Rev. 11:2 (1993), 165–179.
-
(1993)
Cardiovas. Drug Rev.
, vol.11
, Issue.2
, pp. 165-179
-
-
Nials, A.T.1
Vardey, C.J.2
Denyer, L.H.3
Thomas, M.4
Sparrow, S.J.5
Shepherd, G.D.6
Coleman, R.A.7
-
62
-
-
80054927194
-
Effect of PF-04217329 a prodrug of a selective prostaglandin EP(2) agonist on intraocular pressure in preclinical models of glaucoma
-
Prasanna, G., Carreiro, S., Anderson, S., Gukasyan, H., Sartnurak, S., Younis, H., Gale, D., Xiang, C., Wells, P., Dinh, D., Almaden, C., Fortner, J., Toris, C., Niesman, M., Lafontaine, J., Krauss, A., Effect of PF-04217329 a prodrug of a selective prostaglandin EP(2) agonist on intraocular pressure in preclinical models of glaucoma. Exp. Eye Res. 93:3 (2011), 256–264.
-
(2011)
Exp. Eye Res.
, vol.93
, Issue.3
, pp. 256-264
-
-
Prasanna, G.1
Carreiro, S.2
Anderson, S.3
Gukasyan, H.4
Sartnurak, S.5
Younis, H.6
Gale, D.7
Xiang, C.8
Wells, P.9
Dinh, D.10
Almaden, C.11
Fortner, J.12
Toris, C.13
Niesman, M.14
Lafontaine, J.15
Krauss, A.16
-
63
-
-
0028849877
-
6-Isopropoxy-9-oxoxanthene-2-carboxylic acid (AH 6809), a human EP2 receptor antagonist
-
Woodward, D.F., Pepperl, D.J., Burkey, T.H., Regan, J.W., 6-Isopropoxy-9-oxoxanthene-2-carboxylic acid (AH 6809), a human EP2 receptor antagonist. Biochem. Pharmacol. 50:10 (1995), 1731–1733.
-
(1995)
Biochem. Pharmacol.
, vol.50
, Issue.10
, pp. 1731-1733
-
-
Woodward, D.F.1
Pepperl, D.J.2
Burkey, T.H.3
Regan, J.W.4
-
64
-
-
81355128966
-
In vitro and in vivo characterization of PF-04418948, a novel, potent and selective prostaglandin EP(2) receptor antagonist
-
af Forselles, K.J., Root, J., Clarke, T., Davey, D., Aughton, K., Dack, K., Pullen, N., In vitro and in vivo characterization of PF-04418948, a novel, potent and selective prostaglandin EP(2) receptor antagonist. Br. J. Pharmacol. 164:7 (2011), 1847–1856.
-
(2011)
Br. J. Pharmacol.
, vol.164
, Issue.7
, pp. 1847-1856
-
-
af Forselles, K.J.1
Root, J.2
Clarke, T.3
Davey, D.4
Aughton, K.5
Dack, K.6
Pullen, N.7
-
65
-
-
81355124775
-
At last, a truly selective EP(2) receptor antagonist
-
Birrell, M.A., Nials, A.T., At last, a truly selective EP(2) receptor antagonist. Br. J. Pharmacol. 164:7 (2011), 1845–1846.
-
(2011)
Br. J. Pharmacol.
, vol.164
, Issue.7
, pp. 1845-1846
-
-
Birrell, M.A.1
Nials, A.T.2
-
66
-
-
84872856839
-
Selectivity profiling of the novel EP2 receptor antagonist, PF-04418948, in functional bioassay systems: atypical affinity at the Guinea pig EP2 receptor
-
Birrell, M.A., Maher, S.A., Buckley, J., Dale, N., Bonvini, S., Raemdonck, K., Pullen, N., Giembycz, M.A., Belvisi, M.G., Selectivity profiling of the novel EP2 receptor antagonist, PF-04418948, in functional bioassay systems: atypical affinity at the Guinea pig EP2 receptor. Br. J. Pharmacol. 168:1 (2013), 129–138.
-
(2013)
Br. J. Pharmacol.
, vol.168
, Issue.1
, pp. 129-138
-
-
Birrell, M.A.1
Maher, S.A.2
Buckley, J.3
Dale, N.4
Bonvini, S.5
Raemdonck, K.6
Pullen, N.7
Giembycz, M.A.8
Belvisi, M.G.9
-
67
-
-
84857408957
-
Small molecule antagonist reveals seizure-induced mediation of neuronal injury by prostaglandin E2 receptor subtype EP2
-
Jiang, J., Ganesh, T., Du, Y., Quan, Y., Serrano, G., Qui, M., Speigel, I., Rojas, A., Lelutiu, N., Dingledine, R., Small molecule antagonist reveals seizure-induced mediation of neuronal injury by prostaglandin E2 receptor subtype EP2. Proc. Natl. Acad. Sci. U. S. A. 109:8 (2012), 3149–3154.
-
(2012)
Proc. Natl. Acad. Sci. U. S. A.
, vol.109
, Issue.8
, pp. 3149-3154
-
-
Jiang, J.1
Ganesh, T.2
Du, Y.3
Quan, Y.4
Serrano, G.5
Qui, M.6
Speigel, I.7
Rojas, A.8
Lelutiu, N.9
Dingledine, R.10
-
68
-
-
84880142216
-
Discovery and characterization of carbamothioylacrylamides as EP selective antagonists
-
Ganesh, T., Jiang, J., Shashidharamurthy, R., Dingledine, R., Discovery and characterization of carbamothioylacrylamides as EP selective antagonists. ACS Med. Chem. Lett. 4:7 (2013), 616–621.
-
(2013)
ACS Med. Chem. Lett.
, vol.4
, Issue.7
, pp. 616-621
-
-
Ganesh, T.1
Jiang, J.2
Shashidharamurthy, R.3
Dingledine, R.4
-
69
-
-
0032966016
-
Reduction of myocardial injury by the EP3 receptor agonist TEI-3356. Role of protein kinase C and of K(ATP)-channels
-
Zacharowski, K., Olbrich, A., Thiemermann, C., Reduction of myocardial injury by the EP3 receptor agonist TEI-3356. Role of protein kinase C and of K(ATP)-channels. Euro. J. Pharmacol. 367:1 (1999), 33–39.
-
(1999)
Euro. J. Pharmacol.
, vol.367
, Issue.1
, pp. 33-39
-
-
Zacharowski, K.1
Olbrich, A.2
Thiemermann, C.3
-
70
-
-
0035223915
-
Characterization of prostanoid receptors mediating contraction of the gastric fundus and ileum: studies using mice deficient in prostanoid receptors
-
Okada, Y., Hara, A., Ma, H., Xiao, C.Y., Takahata, O., Kohgo, Y., Narumiya, S., Ushikubi, F., Characterization of prostanoid receptors mediating contraction of the gastric fundus and ileum: studies using mice deficient in prostanoid receptors. Br. J. Pharmacol. 131:4 (2000), 745–755.
-
(2000)
Br. J. Pharmacol.
, vol.131
, Issue.4
, pp. 745-755
-
-
Okada, Y.1
Hara, A.2
Ma, H.3
Xiao, C.Y.4
Takahata, O.5
Kohgo, Y.6
Narumiya, S.7
Ushikubi, F.8
-
71
-
-
0031565147
-
Molecular cloning and characterization of the four rat prostaglandin E2 prostanoid receptor subtypes
-
Boie, Y., Stocco, R., Sawyer, N., Slipetz, D.M., Ungrin, M.D., Neuschafer-Rube, F., Puschel, G.P., Metters, K.M., Abramovitz, M., Molecular cloning and characterization of the four rat prostaglandin E2 prostanoid receptor subtypes. Euro. J. Pharmacol. 340:2–3 (1997), 227–241.
-
(1997)
Euro. J. Pharmacol.
, vol.340
, Issue.2-3
, pp. 227-241
-
-
Boie, Y.1
Stocco, R.2
Sawyer, N.3
Slipetz, D.M.4
Ungrin, M.D.5
Neuschafer-Rube, F.6
Puschel, G.P.7
Metters, K.M.8
Abramovitz, M.9
-
72
-
-
0028885078
-
Suppression of naloxone-precipitated withdrawal jumps in morphine-dependent mice by stimulation of prostaglandin EP3 receptor
-
Nakagawa, T., Minami, M., Katsumata, S., Ienaga, Y., Satoh, M., Suppression of naloxone-precipitated withdrawal jumps in morphine-dependent mice by stimulation of prostaglandin EP3 receptor. Br. J. Pharmacol. 116:6 (1995), 2661–2666.
-
(1995)
Br. J. Pharmacol.
, vol.116
, Issue.6
, pp. 2661-2666
-
-
Nakagawa, T.1
Minami, M.2
Katsumata, S.3
Ienaga, Y.4
Satoh, M.5
-
73
-
-
0027431102
-
Third isoform of the prostaglandin-E-receptor EP3 subtype with different C-terminal tail coupling to both stimulation and inhibition of adenylate cyclase
-
Irie, A., Sugimoto, Y., Namba, T., Harazono, A., Honda, A., Watabe, A., Negishi, M., Narumiya, S., Ichikawa, A., Third isoform of the prostaglandin-E-receptor EP3 subtype with different C-terminal tail coupling to both stimulation and inhibition of adenylate cyclase. Eur. J. Biochem. 217:1 (1993), 313–318.
-
(1993)
Eur. J. Biochem.
, vol.217
, Issue.1
, pp. 313-318
-
-
Irie, A.1
Sugimoto, Y.2
Namba, T.3
Harazono, A.4
Honda, A.5
Watabe, A.6
Negishi, M.7
Narumiya, S.8
Ichikawa, A.9
-
74
-
-
0028081597
-
TEI-3356, a highly selective agonist for the prostaglandin EP3 receptor
-
Negishi, M., Harazono, A., Sugimoto, Y., Hazato, A., Kurozumi, S., Ichikawa, A., TEI-3356, a highly selective agonist for the prostaglandin EP3 receptor. Prostaglandins 48:5 (1994), 275–283.
-
(1994)
Prostaglandins
, vol.48
, Issue.5
, pp. 275-283
-
-
Negishi, M.1
Harazono, A.2
Sugimoto, Y.3
Hazato, A.4
Kurozumi, S.5
Ichikawa, A.6
-
75
-
-
0037454960
-
Host prostaglandin E(2)-EP3 signaling regulates tumor-associated angiogenesis and tumor growth
-
Amano, H., Hayashi, I., Endo, H., Kitasato, H., Yamashina, S., Maruyama, T., Kobayashi, M., Satoh, K., Narita, M., Sugimoto, Y., Murata, T., Yoshimura, H., Narumiya, S., Majima, M., Host prostaglandin E(2)-EP3 signaling regulates tumor-associated angiogenesis and tumor growth. J. Exp. Med. 197:2 (2003), 221–232.
-
(2003)
J. Exp. Med.
, vol.197
, Issue.2
, pp. 221-232
-
-
Amano, H.1
Hayashi, I.2
Endo, H.3
Kitasato, H.4
Yamashina, S.5
Maruyama, T.6
Kobayashi, M.7
Satoh, K.8
Narita, M.9
Sugimoto, Y.10
Murata, T.11
Yoshimura, H.12
Narumiya, S.13
Majima, M.14
-
76
-
-
70449528788
-
Prostaglandin E2 mediates cough via the EP3 receptor: implications for future disease therapy
-
Maher, S.A., Birrell, M.A., Belvisi, M.G., Prostaglandin E2 mediates cough via the EP3 receptor: implications for future disease therapy. Am. J. Res. Critical Care Med. 180:10 (2009), 923–928.
-
(2009)
Am. J. Res. Critical Care Med.
, vol.180
, Issue.10
, pp. 923-928
-
-
Maher, S.A.1
Birrell, M.A.2
Belvisi, M.G.3
-
77
-
-
29844444786
-
Role of periaqueductal grey prostaglandin receptors in formalin-induced hyperalgesia
-
Oliva, P., Berrino, L., de Novellis, V., Palazzo, E., Marabese, I., Siniscalco, D., Scafuro, M., Mariani, L., Rossi, F., Maione, S., Role of periaqueductal grey prostaglandin receptors in formalin-induced hyperalgesia. Euro. J. Pharmaco. 530:1–2 (2006), 40–47.
-
(2006)
Euro. J. Pharmaco.
, vol.530
, Issue.1-2
, pp. 40-47
-
-
Oliva, P.1
Berrino, L.2
de Novellis, V.3
Palazzo, E.4
Marabese, I.5
Siniscalco, D.6
Scafuro, M.7
Mariani, L.8
Rossi, F.9
Maione, S.10
-
78
-
-
57049124328
-
Modulation of bladder function by prostaglandin EP3 receptors in the central nervous system
-
Su, X., Leon, L.A., Wu, C.W., Morrow, D.M., Jaworski, J.P., Hieble, J.P., Lashinger, E.S., Jin, J., Edwards, R.M., Laping, N.J., Modulation of bladder function by prostaglandin EP3 receptors in the central nervous system. Am. J. Physiol. Renal. Physiol. 295:4 (2008), F984–F994.
-
(2008)
Am. J. Physiol. Renal. Physiol.
, vol.295
, Issue.4
, pp. F984-F994
-
-
Su, X.1
Leon, L.A.2
Wu, C.W.3
Morrow, D.M.4
Jaworski, J.P.5
Hieble, J.P.6
Lashinger, E.S.7
Jin, J.8
Edwards, R.M.9
Laping, N.J.10
-
79
-
-
65249093133
-
Antagonists of the EP3 receptor for prostaglandin E2 are novel antiplatelet agents that do not prolong bleeding
-
Singh, J., Zeller, W., Zhou, N., Hategen, G., Mishra, R., Polozov, A., Yu, P., Onua, E., Zhang, J., Zembower, D., Kiselyov, A., Ramirez, J.L., Sigthorsson, G., Bjornsson, J.M., Thorsteinsdottir, M., Andresson, T., Bjarnadottir, M., Magnusson, O., Fabre, J.E., Stefansson, K., Gurney, M.E., Antagonists of the EP3 receptor for prostaglandin E2 are novel antiplatelet agents that do not prolong bleeding. ACS Chem. Biol. 4:2 (2009), 115–126.
-
(2009)
ACS Chem. Biol.
, vol.4
, Issue.2
, pp. 115-126
-
-
Singh, J.1
Zeller, W.2
Zhou, N.3
Hategen, G.4
Mishra, R.5
Polozov, A.6
Yu, P.7
Onua, E.8
Zhang, J.9
Zembower, D.10
Kiselyov, A.11
Ramirez, J.L.12
Sigthorsson, G.13
Bjornsson, J.M.14
Thorsteinsdottir, M.15
Andresson, T.16
Bjarnadottir, M.17
Magnusson, O.18
Fabre, J.E.19
Stefansson, K.20
Gurney, M.E.21
more..
-
80
-
-
0037463795
-
Discovery of a potent and selective agonist of the prostaglandin EP4 receptor
-
Billot, X., Chateauneuf, A., Chauret, N., Denis, D., Greig, G., Mathieu, M.C., Metters, K.M., Slipetz, D.M., Young, R.N., Discovery of a potent and selective agonist of the prostaglandin EP4 receptor. Bioorg. Med. Chem. Lett. 13:6 (2003), 1129–1132.
-
(2003)
Bioorg. Med. Chem. Lett.
, vol.13
, Issue.6
, pp. 1129-1132
-
-
Billot, X.1
Chateauneuf, A.2
Chauret, N.3
Denis, D.4
Greig, G.5
Mathieu, M.C.6
Metters, K.M.7
Slipetz, D.M.8
Young, R.N.9
-
81
-
-
34347403843
-
Discovery of novel prostaglandin analogs of PGE2 as potent and selective EP2 and EP4 receptor agonists
-
Xiao, Y., Araldi, G.L., Zhao, Z., Brugger, N., Karra, S., Fischer, D., Palmer, E., Discovery of novel prostaglandin analogs of PGE2 as potent and selective EP2 and EP4 receptor agonists. Bioorg. Med. Chem. Lett. 17:15 (2007), 4323–4327.
-
(2007)
Bioorg. Med. Chem. Lett.
, vol.17
, Issue.15
, pp. 4323-4327
-
-
Xiao, Y.1
Araldi, G.L.2
Zhao, Z.3
Brugger, N.4
Karra, S.5
Fischer, D.6
Palmer, E.7
-
82
-
-
0036221333
-
The prostaglandin receptor EP4 suppresses colitis, mucosal damage and CD4 cell activation in the gut
-
Kabashima, K., Saji, T., Murata, T., Nagamachi, M., Matsuoka, T., Segi, E., Tsuboi, K., Sugimoto, Y., Kobayashi, T., Miyachi, Y., Ichikawa, A., Narumiya, S., The prostaglandin receptor EP4 suppresses colitis, mucosal damage and CD4 cell activation in the gut. J. Clin. Invest. 109:7 (2002), 883–893.
-
(2002)
J. Clin. Invest.
, vol.109
, Issue.7
, pp. 883-893
-
-
Kabashima, K.1
Saji, T.2
Murata, T.3
Nagamachi, M.4
Matsuoka, T.5
Segi, E.6
Tsuboi, K.7
Sugimoto, Y.8
Kobayashi, T.9
Miyachi, Y.10
Ichikawa, A.11
Narumiya, S.12
-
83
-
-
81555216781
-
EP4 receptor as a new target for bronchodilator therapy
-
Buckley, J., Birrell, M.A., Maher, S.A., Nials, A.T., Clarke, D.L., Belvisi, M.G., EP4 receptor as a new target for bronchodilator therapy. Thorax 66:12 (2011), 1029–1035.
-
(2011)
Thorax
, vol.66
, Issue.12
, pp. 1029-1035
-
-
Buckley, J.1
Birrell, M.A.2
Maher, S.A.3
Nials, A.T.4
Clarke, D.L.5
Belvisi, M.G.6
-
84
-
-
84856771780
-
PGE(2) receptor (EP(4)) agonists: potent dilators of human bronchi and future asthma therapy?
-
Benyahia, C., Gomez, I., Kanyinda, L., Boukais, K., Danel, C., Leseche, G., Longrois, D., Norel, X., PGE(2) receptor (EP(4)) agonists: potent dilators of human bronchi and future asthma therapy?. Pulm. Pharmacol. Ther. 25:1 (2012), 115–118.
-
(2012)
Pulm. Pharmacol. Ther.
, vol.25
, Issue.1
, pp. 115-118
-
-
Benyahia, C.1
Gomez, I.2
Kanyinda, L.3
Boukais, K.4
Danel, C.5
Leseche, G.6
Longrois, D.7
Norel, X.8
-
85
-
-
80054735367
-
EP4 receptor stimulation down-regulates human eosinophil function
-
Luschnig-Schratl, P., Sturm, E.M., Konya, V., Philipose, S., Marsche, G., Frohlich, E., Samberger, C., Lang-Loidolt, D., Gattenlohner, S., Lippe, I.T., Peskar, B.A., Schuligoi, R., Heinemann, A., EP4 receptor stimulation down-regulates human eosinophil function. Cell Mol. Life Sci. 68:21 (2011), 3573–3587.
-
(2011)
Cell Mol. Life Sci.
, vol.68
, Issue.21
, pp. 3573-3587
-
-
Luschnig-Schratl, P.1
Sturm, E.M.2
Konya, V.3
Philipose, S.4
Marsche, G.5
Frohlich, E.6
Samberger, C.7
Lang-Loidolt, D.8
Gattenlohner, S.9
Lippe, I.T.10
Peskar, B.A.11
Schuligoi, R.12
Heinemann, A.13
-
86
-
-
84855337395
-
Prostaglandin E2 enhances interleukin-8 production via EP4 receptor in human pulmonary microvascular endothelial cells
-
Aso, H., Ito, S., Mori, A., Morioka, M., Suganuma, N., Kondo, M., Imaizumi, K., Hasegawa, Y., Prostaglandin E2 enhances interleukin-8 production via EP4 receptor in human pulmonary microvascular endothelial cells. Am. J. Physiol. Lung Cell. Mol. Physiol. 302:2 (2012), L266–L273.
-
(2012)
Am. J. Physiol. Lung Cell. Mol. Physiol.
, vol.302
, Issue.2
, pp. L266-L273
-
-
Aso, H.1
Ito, S.2
Mori, A.3
Morioka, M.4
Suganuma, N.5
Kondo, M.6
Imaizumi, K.7
Hasegawa, Y.8
-
87
-
-
49449107477
-
Vasorelaxation induced by prostaglandin E2 in human pulmonary vein: role of the EP4 receptor subtype
-
Foudi, N., Kotelevets, L., Louedec, L., Leseche, G., Henin, D., Chastre, E., Norel, X., Vasorelaxation induced by prostaglandin E2 in human pulmonary vein: role of the EP4 receptor subtype. Br. J. Pharmacol. 154:8 (2008), 1631–1639.
-
(2008)
Br. J. Pharmacol.
, vol.154
, Issue.8
, pp. 1631-1639
-
-
Foudi, N.1
Kotelevets, L.2
Louedec, L.3
Leseche, G.4
Henin, D.5
Chastre, E.6
Norel, X.7
-
88
-
-
79955575162
-
International Union of Basic and Clinical Pharmacology. LXXXIII: classification of prostanoid receptors, updating 15 years of progress
-
Woodward, D.F., Jones, R.L., Narumiya, S., International Union of Basic and Clinical Pharmacology. LXXXIII: classification of prostanoid receptors, updating 15 years of progress. Pharmacol. Rev. 63:3 (2011), 471–538.
-
(2011)
Pharmacol. Rev.
, vol.63
, Issue.3
, pp. 471-538
-
-
Woodward, D.F.1
Jones, R.L.2
Narumiya, S.3
-
89
-
-
33744490979
-
GW627368X ((N-{2-[4-(4,9-diethoxy-1-oxo-1,3-dihydro-2H-benzo[f]isoindol-2-yl)phenyl]acetyl} benzene sulphonamide): a novel, potent and selective prostanoid EP4 receptor antagonist
-
Wilson, R.J., Giblin, G.M., Roomans, S., Rhodes, S.A., Cartwright, K.A., Shield, V.J., Brown, J., Wise, A., Chowdhury, J., Pritchard, S., Coote, J., Noel, L.S., Kenakin, T., Burns-Kurtis, C.L., Morrison, V., Gray, D.W., Giles, H., GW627368X ((N-{2-[4-(4,9-diethoxy-1-oxo-1,3-dihydro-2H-benzo[f]isoindol-2-yl)phenyl]acetyl} benzene sulphonamide): a novel, potent and selective prostanoid EP4 receptor antagonist. Br. J. Pharmacol. 148:3 (2006), 326–339.
-
(2006)
Br. J. Pharmacol.
, vol.148
, Issue.3
, pp. 326-339
-
-
Wilson, R.J.1
Giblin, G.M.2
Roomans, S.3
Rhodes, S.A.4
Cartwright, K.A.5
Shield, V.J.6
Brown, J.7
Wise, A.8
Chowdhury, J.9
Pritchard, S.10
Coote, J.11
Noel, L.S.12
Kenakin, T.13
Burns-Kurtis, C.L.14
Morrison, V.15
Gray, D.W.16
Giles, H.17
-
90
-
-
0033845789
-
Pharmacological characterization of [(3)H]-prostaglandin E(2) binding to the cloned human EP(4) prostanoid receptor
-
Davis, T.L., Sharif, N.A., Pharmacological characterization of [(3)H]-prostaglandin E(2) binding to the cloned human EP(4) prostanoid receptor. Br. J. Pharmacol. 130:8 (2000), 1919–1926.
-
(2000)
Br. J. Pharmacol.
, vol.130
, Issue.8
, pp. 1919-1926
-
-
Davis, T.L.1
Sharif, N.A.2
-
91
-
-
34547097777
-
CJ-023,423, a novel, potent and selective prostaglandin EP4 receptor antagonist with antihyperalgesic properties
-
Nakao, K., Murase, A., Ohshiro, H., Okumura, T., Taniguchi, K., Murata, Y., Masuda, M., Kato, T., Okumura, Y., Takada, J., CJ-023,423, a novel, potent and selective prostaglandin EP4 receptor antagonist with antihyperalgesic properties. J. Pharmacol. Exp. Ther. 322:2 (2007), 686–694.
-
(2007)
J. Pharmacol. Exp. Ther.
, vol.322
, Issue.2
, pp. 686-694
-
-
Nakao, K.1
Murase, A.2
Ohshiro, H.3
Okumura, T.4
Taniguchi, K.5
Murata, Y.6
Masuda, M.7
Kato, T.8
Okumura, Y.9
Takada, J.10
-
92
-
-
37649015323
-
In vitro pharmacological characterization of CJ-042794, a novel, potent, and selective prostaglandin EP(4) receptor antagonist
-
Murase, A., Taniguchi, Y., Tonai-Kachi, H., Nakao, K., Takada, J., In vitro pharmacological characterization of CJ-042794, a novel, potent, and selective prostaglandin EP(4) receptor antagonist. Life Sci. 82:3–4 (2008), 226–232.
-
(2008)
Life Sci.
, vol.82
, Issue.3-4
, pp. 226-232
-
-
Murase, A.1
Taniguchi, Y.2
Tonai-Kachi, H.3
Nakao, K.4
Takada, J.5
-
93
-
-
77954213066
-
Discovery of 4-[1-[([1-[4-(trifluoromethyl)benzyl]-1H-indol-7-yl]carbonyl)amino]cyclopropyl]be nzoic acid (MF-766), a highly potent and selective EP4 antagonist for treating inflammatory pain
-
Colucci, J., Boyd, M., Berthelette, C., Chiasson, J.F., Wang, Z., Ducharme, Y., Friesen, R., Wrona, M., Levesque, J.F., Denis, D., Mathieu, M.C., Stocco, R., Therien, A.G., Clarke, P., Rowland, S., Xu, D., Han, Y., Discovery of 4-[1-[([1-[4-(trifluoromethyl)benzyl]-1H-indol-7-yl]carbonyl)amino]cyclopropyl]be nzoic acid (MF-766), a highly potent and selective EP4 antagonist for treating inflammatory pain. Bioorg. Med. Chem. Lett. 20:12 (2010), 3760–3763.
-
(2010)
Bioorg. Med. Chem. Lett.
, vol.20
, Issue.12
, pp. 3760-3763
-
-
Colucci, J.1
Boyd, M.2
Berthelette, C.3
Chiasson, J.F.4
Wang, Z.5
Ducharme, Y.6
Friesen, R.7
Wrona, M.8
Levesque, J.F.9
Denis, D.10
Mathieu, M.C.11
Stocco, R.12
Therien, A.G.13
Clarke, P.14
Rowland, S.15
Xu, D.16
Han, Y.17
-
94
-
-
0037110742
-
Prostaglandin E2 suppresses chemokine production in human macrophages through the EP4 receptor
-
Takayama, K., Garcia-Cardena, G., Sukhova, G.K., Comander, J., Gimbrone, M.A. Jr., Libby, P., Prostaglandin E2 suppresses chemokine production in human macrophages through the EP4 receptor. J. Biol. Chem. 277:46 (2002), 44147–44154.
-
(2002)
J. Biol. Chem.
, vol.277
, Issue.46
, pp. 44147-44154
-
-
Takayama, K.1
Garcia-Cardena, G.2
Sukhova, G.K.3
Comander, J.4
Gimbrone, M.A.5
Libby, P.6
-
95
-
-
0034954444
-
Prostaglandin receptor EP(4) mediates the bone anabolic effects of PGE(2)
-
Machwate, M., Harada, S., Leu, C.T., Seedor, G., Labelle, M., Gallant, M., Hutchins, S., Lachance, N., Sawyer, N., Slipetz, D., Metters, K.M., Rodan, S.B., Young, R., Rodan, G.A., Prostaglandin receptor EP(4) mediates the bone anabolic effects of PGE(2). Mol. Pharmacol. 60:1 (2001), 36–41.
-
(2001)
Mol. Pharmacol.
, vol.60
, Issue.1
, pp. 36-41
-
-
Machwate, M.1
Harada, S.2
Leu, C.T.3
Seedor, G.4
Labelle, M.5
Gallant, M.6
Hutchins, S.7
Lachance, N.8
Sawyer, N.9
Slipetz, D.10
Metters, K.M.11
Rodan, S.B.12
Young, R.13
Rodan, G.A.14
-
96
-
-
67650270396
-
BGC20-1531, a novel, potent and selective prostanoid EP receptor antagonist: a putative new treatment for migraine headache
-
Maubach, K.A., Davis, R.J., Clark, D.E., Fenton, G., Lockey, P.M., Clark, K.L., Oxford, A.W., Hagan, R.M., Routledge, C., Coleman, R.A., BGC20-1531, a novel, potent and selective prostanoid EP receptor antagonist: a putative new treatment for migraine headache. Br. J. Pharmacol. 156:2 (2009), 316–327.
-
(2009)
Br. J. Pharmacol.
, vol.156
, Issue.2
, pp. 316-327
-
-
Maubach, K.A.1
Davis, R.J.2
Clark, D.E.3
Fenton, G.4
Lockey, P.M.5
Clark, K.L.6
Oxford, A.W.7
Hagan, R.M.8
Routledge, C.9
Coleman, R.A.10
-
97
-
-
0032541676
-
Impaired febrile response in mice lacking the prostaglandin E receptor subtype EP3
-
Ushikubi, F., Segi, E., Sugimoto, Y., Murata, T., Matsuoka, T., Kobayashi, T., Hizaki, H., Tuboi, K., Katsuyama, M., Ichikawa, A., Tanaka, T., Yoshida, N., Narumiya, S., Impaired febrile response in mice lacking the prostaglandin E receptor subtype EP3. Nature 395:6699 (1998), 281–284.
-
(1998)
Nature
, vol.395
, Issue.6699
, pp. 281-284
-
-
Ushikubi, F.1
Segi, E.2
Sugimoto, Y.3
Murata, T.4
Matsuoka, T.5
Kobayashi, T.6
Hizaki, H.7
Tuboi, K.8
Katsuyama, M.9
Ichikawa, A.10
Tanaka, T.11
Yoshida, N.12
Narumiya, S.13
-
98
-
-
84940465627
-
Anti-inflammatory effects of PGE2 in the lung: role of the EP4 receptor subtype
-
Birrell, M.A., Maher, S.A., Dekkak, B., Jones, V., Wong, S., Brook, P., Belvisi, M.G., Anti-inflammatory effects of PGE2 in the lung: role of the EP4 receptor subtype. Thorax 70:8 (2015), 740–747.
-
(2015)
Thorax
, vol.70
, Issue.8
, pp. 740-747
-
-
Birrell, M.A.1
Maher, S.A.2
Dekkak, B.3
Jones, V.4
Wong, S.5
Brook, P.6
Belvisi, M.G.7
-
99
-
-
84960078092
-
Role of EP2 and EP4 receptors in airway microvascular leak induced by prostaglandin E2
-
Jones, V.C., Birrell, M.A., Maher, S.A., Griffiths, M., Grace, M., O'Donnell, V.B., Clark, S.R., Belvisi, M.G., Role of EP2 and EP4 receptors in airway microvascular leak induced by prostaglandin E2. Brit. J. Pharmacol. 173:6 (2016), 992–1004.
-
(2016)
Brit. J. Pharmacol.
, vol.173
, Issue.6
, pp. 992-1004
-
-
Jones, V.C.1
Birrell, M.A.2
Maher, S.A.3
Griffiths, M.4
Grace, M.5
O'Donnell, V.B.6
Clark, S.R.7
Belvisi, M.G.8
-
100
-
-
84873160340
-
Pro-inflammatory and immunomodulatory functions of airway smooth muscle: emerging concepts
-
Xia, Y.C., Redhu, N.S., Moir, L.M., Koziol-White, C., Ammit, A.J., Al-Alwan, L., Camoretti-Mercado, B., Clifford, R.L., Pro-inflammatory and immunomodulatory functions of airway smooth muscle: emerging concepts. Pulm. Pharmacol. Ther. 26:1 (2013), 64–74.
-
(2013)
Pulm. Pharmacol. Ther.
, vol.26
, Issue.1
, pp. 64-74
-
-
Xia, Y.C.1
Redhu, N.S.2
Moir, L.M.3
Koziol-White, C.4
Ammit, A.J.5
Al-Alwan, L.6
Camoretti-Mercado, B.7
Clifford, R.L.8
-
101
-
-
12144251393
-
Prostanoid receptor expression by human airway smooth muscle cells and regulation of the secretion of granulocyte colony-stimulating factor
-
Clarke, D.L., Belvisi, M.G., Smith, S.J., Hardaker, E., Yacoub, M.H., Meja, K.K., Newton, R., Slater, D.M., Giembycz, M.A., Prostanoid receptor expression by human airway smooth muscle cells and regulation of the secretion of granulocyte colony-stimulating factor. Am. J. Physiol. Lung Cell. Mol. Physiol. 288:2 (2005), L238–L250.
-
(2005)
Am. J. Physiol. Lung Cell. Mol. Physiol.
, vol.288
, Issue.2
, pp. L238-L250
-
-
Clarke, D.L.1
Belvisi, M.G.2
Smith, S.J.3
Hardaker, E.4
Yacoub, M.H.5
Meja, K.K.6
Newton, R.7
Slater, D.M.8
Giembycz, M.A.9
-
102
-
-
24044529450
-
Vascular endothelial growth factor induction by prostaglandin E2 in human airway smooth muscle cells is mediated by E prostanoid EP2/EP4 receptors and SP-1 transcription factor binding sites
-
Bradbury, D., Clarke, D., Seedhouse, C., Corbett, L., Stocks, J., Knox, A., Vascular endothelial growth factor induction by prostaglandin E2 in human airway smooth muscle cells is mediated by E prostanoid EP2/EP4 receptors and SP-1 transcription factor binding sites. J. Biol. Chem. 280:34 (2005), 29993–30000.
-
(2005)
J. Biol. Chem.
, vol.280
, Issue.34
, pp. 29993-30000
-
-
Bradbury, D.1
Clarke, D.2
Seedhouse, C.3
Corbett, L.4
Stocks, J.5
Knox, A.6
-
103
-
-
79958785669
-
Effects of specific prostanoid EP receptor agonists on cell proliferation and intracellular Ca(2+) concentrations in human airway smooth muscle cells
-
Mori, A., Ito, S., Morioka, M., Aso, H., Kondo, M., Sokabe, M., Hasegawa, Y., Effects of specific prostanoid EP receptor agonists on cell proliferation and intracellular Ca(2+) concentrations in human airway smooth muscle cells. Euro. J. Pharmaco. 659:1 (2011), 72–78.
-
(2011)
Euro. J. Pharmaco.
, vol.659
, Issue.1
, pp. 72-78
-
-
Mori, A.1
Ito, S.2
Morioka, M.3
Aso, H.4
Kondo, M.5
Sokabe, M.6
Hasegawa, Y.7
-
104
-
-
70350320406
-
Increased vascular permeability precedes cellular inflammation as asthma control deteriorates
-
Khor, Y.H., Teoh, A.K., Lam, S.M., Mo, D.C., Weston, S., Reid, D.W., Walters, E.H., Increased vascular permeability precedes cellular inflammation as asthma control deteriorates. Clin. Exp. Allergy 39:11 (2009), 1659–1667.
-
(2009)
Clin. Exp. Allergy
, vol.39
, Issue.11
, pp. 1659-1667
-
-
Khor, Y.H.1
Teoh, A.K.2
Lam, S.M.3
Mo, D.C.4
Weston, S.5
Reid, D.W.6
Walters, E.H.7
-
105
-
-
84860350809
-
Levels of angiopoietins 1 and 2 in induced sputum supernatant in patients with COPD
-
Bessa, V., Loukides, S., Hillas, G., Delimpoura, V., Simoes, D., Kontogianni, K., Papiris, S., Kostikas, K., Alchanatis, M., Bakakos, P., Levels of angiopoietins 1 and 2 in induced sputum supernatant in patients with COPD. Cytokine 58:3 (2012), 455–460.
-
(2012)
Cytokine
, vol.58
, Issue.3
, pp. 455-460
-
-
Bessa, V.1
Loukides, S.2
Hillas, G.3
Delimpoura, V.4
Simoes, D.5
Kontogianni, K.6
Papiris, S.7
Kostikas, K.8
Alchanatis, M.9
Bakakos, P.10
-
106
-
-
0035671188
-
Prostanoid EP(1)- and TP-receptors involved in the contraction of human pulmonary veins
-
Walch, L., de Montpreville, V., Brink, C., Norel, X., Prostanoid EP(1)- and TP-receptors involved in the contraction of human pulmonary veins. Br. J. Pharmacol. 134:8 (2001), 1671–1678.
-
(2001)
Br. J. Pharmacol.
, vol.134
, Issue.8
, pp. 1671-1678
-
-
Walch, L.1
de Montpreville, V.2
Brink, C.3
Norel, X.4
-
107
-
-
0031001397
-
Mast cell numbers are increased in the smooth muscle of human sensitized isolated bronchi
-
Ammit, A.J., Bekir, S.S., Johnson, P.R., Hughes, J.M., Armour, C.L., Black, J.L., Mast cell numbers are increased in the smooth muscle of human sensitized isolated bronchi. Am. J. Res. Crit. Care Med. 155:3 (1997), 1123–1129.
-
(1997)
Am. J. Res. Crit. Care Med.
, vol.155
, Issue.3
, pp. 1123-1129
-
-
Ammit, A.J.1
Bekir, S.S.2
Johnson, P.R.3
Hughes, J.M.4
Armour, C.L.5
Black, J.L.6
-
108
-
-
0035217668
-
Human mast cell and airway smooth muscle cell interactions: implications for asthma
-
Page, S., Ammit, A.J., Black, J.L., Armour, C.L., Human mast cell and airway smooth muscle cell interactions: implications for asthma. Am. J. Physiol. Lung Cellular Mol. Physiol. 281:6 (2001), L1313–L1323.
-
(2001)
Am. J. Physiol. Lung Cellular Mol. Physiol.
, vol.281
, Issue.6
, pp. L1313-L1323
-
-
Page, S.1
Ammit, A.J.2
Black, J.L.3
Armour, C.L.4
-
109
-
-
18644380441
-
The CXCL10/CXCR3 axis mediates human lung mast cell migration to asthmatic airway smooth muscle
-
Brightling, C.E., Ammit, A.J., Kaur, D., Black, J.L., Wardlaw, A.J., Hughes, J.M., Bradding, P., The CXCL10/CXCR3 axis mediates human lung mast cell migration to asthmatic airway smooth muscle. Am. J. Res. Crit. Care Med. 171:10 (2005), 1103–1108.
-
(2005)
Am. J. Res. Crit. Care Med.
, vol.171
, Issue.10
, pp. 1103-1108
-
-
Brightling, C.E.1
Ammit, A.J.2
Kaur, D.3
Black, J.L.4
Wardlaw, A.J.5
Hughes, J.M.6
Bradding, P.7
-
110
-
-
0031806385
-
Influence of receptor reserve on beta-adrenoceptor-mediated responses in human lung mast cells
-
Drury, D.E., Chong, L.K., Ghahramani, P., Peachell, P.T., Influence of receptor reserve on beta-adrenoceptor-mediated responses in human lung mast cells. Br. J. Pharmacol. 124:4 (1998), 711–718.
-
(1998)
Br. J. Pharmacol.
, vol.124
, Issue.4
, pp. 711-718
-
-
Drury, D.E.1
Chong, L.K.2
Ghahramani, P.3
Peachell, P.T.4
-
111
-
-
33645553017
-
Prostaglandin E2 activates EP2 receptors to inhibit human lung mast cell degranulation
-
Kay, L.J., Yeo, W.W., Peachell, P.T., Prostaglandin E2 activates EP2 receptors to inhibit human lung mast cell degranulation. Br. J. Pharmacol. 147:7 (2006), 707–713.
-
(2006)
Br. J. Pharmacol.
, vol.147
, Issue.7
, pp. 707-713
-
-
Kay, L.J.1
Yeo, W.W.2
Peachell, P.T.3
-
112
-
-
84879525264
-
Characterization of the EP receptor subtype that mediates the inhibitory effects of prostaglandin E2 on IgE-dependent secretion from human lung mast cells
-
Kay, L.J., Gilbert, M., Pullen, N., Skerratt, S., Farrington, J., Seward, E.P., Peachell, P.T., Characterization of the EP receptor subtype that mediates the inhibitory effects of prostaglandin E2 on IgE-dependent secretion from human lung mast cells. Clin. Exp. Allergy 43:7 (2013), 741–751.
-
(2013)
Clin. Exp. Allergy
, vol.43
, Issue.7
, pp. 741-751
-
-
Kay, L.J.1
Gilbert, M.2
Pullen, N.3
Skerratt, S.4
Farrington, J.5
Seward, E.P.6
Peachell, P.T.7
-
113
-
-
85027929067
-
Prostaglandin E2 inhibits mast cell-dependent bronchoconstriction in human small airways through the E prostanoid subtype 2 receptor
-
e1
-
Safholm, J., Manson, M.L., Bood, J., Delin, I., Orre, A.C., Bergman, P., Al-Ameri, M., Dahlen, S.E., Adner, M., Prostaglandin E2 inhibits mast cell-dependent bronchoconstriction in human small airways through the E prostanoid subtype 2 receptor. J. Allergy Clin. Immunol. 136:5 (2015), 1232–1239 e1.
-
(2015)
J. Allergy Clin. Immunol.
, vol.136
, Issue.5
, pp. 1232-1239
-
-
Safholm, J.1
Manson, M.L.2
Bood, J.3
Delin, I.4
Orre, A.C.5
Bergman, P.6
Al-Ameri, M.7
Dahlen, S.E.8
Adner, M.9
-
114
-
-
84880045926
-
Pathogenesis of exercise-induced bronchoconstriction
-
(vii)
-
Kippelen, P., Anderson, S.D., Pathogenesis of exercise-induced bronchoconstriction. Immunol. Allergy Clin. N. Am. 33:3 (2013), 299–312 (vii).
-
(2013)
Immunol. Allergy Clin. N. Am.
, vol.33
, Issue.3
, pp. 299-312
-
-
Kippelen, P.1
Anderson, S.D.2
-
115
-
-
84908191493
-
Prostaglandin E2 prevents hyperosmolar-induced human mast cell activation through prostanoid receptors EP2 and EP4
-
Torres-Atencio, I., Ainsua-Enrich, E., de Mora, F., Picado, C., Martin, M., Prostaglandin E2 prevents hyperosmolar-induced human mast cell activation through prostanoid receptors EP2 and EP4. PLoS One, 9(10), 2014, e110870.
-
(2014)
PLoS One
, vol.9
, Issue.10
-
-
Torres-Atencio, I.1
Ainsua-Enrich, E.2
de Mora, F.3
Picado, C.4
Martin, M.5
-
116
-
-
0028911427
-
Bronchoprotective role for endogenous prostaglandin E2
-
Pavord, I.D., Tattersfield, A.E., Bronchoprotective role for endogenous prostaglandin E2. Lancet 345:8947 (1995), 436–438.
-
(1995)
Lancet
, vol.345
, Issue.8947
, pp. 436-438
-
-
Pavord, I.D.1
Tattersfield, A.E.2
-
117
-
-
0032909759
-
Prostanoid receptors involved in the relaxation of human bronchial preparations
-
Norel, X., Walch, L., Labat, C., Gascard, J.P., Dulmet, E., Brink, C., Prostanoid receptors involved in the relaxation of human bronchial preparations. Br. J. Pharmacol. 126:4 (1999), 867–872.
-
(1999)
Br. J. Pharmacol.
, vol.126
, Issue.4
, pp. 867-872
-
-
Norel, X.1
Walch, L.2
Labat, C.3
Gascard, J.P.4
Dulmet, E.5
Brink, C.6
-
118
-
-
0022359704
-
Characteristics of prostaglandin induced cough in man
-
Costello, J.F., Dunlop, L.S., Gardiner, P.J., Characteristics of prostaglandin induced cough in man. Br. J. Clin. Pharmacol. 20:4 (1985), 355–359.
-
(1985)
Br. J. Clin. Pharmacol.
, vol.20
, Issue.4
, pp. 355-359
-
-
Costello, J.F.1
Dunlop, L.S.2
Gardiner, P.J.3
-
119
-
-
77949273337
-
Prostanoids and the cough reflex
-
Maher, S.A., Belvisi, M.G., Prostanoids and the cough reflex. Lung 188:Suppl 1 (2010), S9–S12.
-
(2010)
Lung
, vol.188
, pp. S9-S12
-
-
Maher, S.A.1
Belvisi, M.G.2
-
120
-
-
84866090064
-
Transient receptor potential channels mediate the tussive response to prostaglandin E2 and bradykinin
-
Grace, M., Birrell, M.A., Dubuis, E., Maher, S.A., Belvisi, M.G., Transient receptor potential channels mediate the tussive response to prostaglandin E2 and bradykinin. Thorax 67:10 (2012), 891–900.
-
(2012)
Thorax
, vol.67
, Issue.10
, pp. 891-900
-
-
Grace, M.1
Birrell, M.A.2
Dubuis, E.3
Maher, S.A.4
Belvisi, M.G.5
-
121
-
-
85022007752
-
Cough and airway disease: the role of ion channels
-
Epub 2017 Jun 29
-
Bonvini, S.J., Belvisi, M.G., Cough and airway disease: the role of ion channels. Pulm. Pharmacol. Ther. 47 (2017 Dec), 21–28, 10.1016/j.pupt.2017.06.009 Epub 2017 Jun 29.
-
(2017)
Pulm. Pharmacol. Ther.
, vol.47
, pp. 21-28
-
-
Bonvini, S.J.1
Belvisi, M.G.2
-
122
-
-
72749127813
-
Prostaglandin E(2) induces fibroblast apoptosis by modulating multiple survival pathways
-
Huang, S.K., White, E.S., Wettlaufer, S.H., Grifka, H., Hogaboam, C.M., Thannickal, V.J., Horowitz, J.C., Peters-Golden, M., Prostaglandin E(2) induces fibroblast apoptosis by modulating multiple survival pathways. FASEB J 23:12 (2009), 4317–4326.
-
(2009)
FASEB J
, vol.23
, Issue.12
, pp. 4317-4326
-
-
Huang, S.K.1
White, E.S.2
Wettlaufer, S.H.3
Grifka, H.4
Hogaboam, C.M.5
Thannickal, V.J.6
Horowitz, J.C.7
Peters-Golden, M.8
-
123
-
-
84886529171
-
Phosphodiesterase-4 inhibition augments human lung fibroblast vascular endothelial growth factor production induced by prostaglandin E2
-
Ikari, J., Michalski, J.M., Iwasawa, S., Gunji, Y., Nogel, S., Park, J.H., Nelson, A.J., Farid, M., Wang, X., Schulte, N., Basma, H., Toews, M.L., Feghali-Bostwick, C., Tenor, H., Liu, X., Rennard, S.I., Phosphodiesterase-4 inhibition augments human lung fibroblast vascular endothelial growth factor production induced by prostaglandin E2. Am. J. Resp. Cell Mol. Biol. 49:4 (2013), 571–581.
-
(2013)
Am. J. Resp. Cell Mol. Biol.
, vol.49
, Issue.4
, pp. 571-581
-
-
Ikari, J.1
Michalski, J.M.2
Iwasawa, S.3
Gunji, Y.4
Nogel, S.5
Park, J.H.6
Nelson, A.J.7
Farid, M.8
Wang, X.9
Schulte, N.10
Basma, H.11
Toews, M.L.12
Feghali-Bostwick, C.13
Tenor, H.14
Liu, X.15
Rennard, S.I.16
-
124
-
-
85013098594
-
Senescence in COPD and its comorbidities
-
Barnes, P.J., Senescence in COPD and its comorbidities. Ann. Rev. Physiol. 79 (2017), 517–539.
-
(2017)
Ann. Rev. Physiol.
, vol.79
, pp. 517-539
-
-
Barnes, P.J.1
-
125
-
-
84875849501
-
The cyclooxygenase-2-prostaglandin E2 pathway maintains senescence of chronic obstructive pulmonary disease fibroblasts
-
Dagouassat, M., Gagliolo, J.M., Chrusciel, S., Bourin, M.C., Duprez, C., Caramelle, P., Boyer, L., Hue, S., Stern, J.B., Validire, P., Longrois, D., Norel, X., Dubois-Rande, J.L., Le Gouvello, S., Adnot, S., Boczkowski, J., The cyclooxygenase-2-prostaglandin E2 pathway maintains senescence of chronic obstructive pulmonary disease fibroblasts. Am. J. Resp. Crit. Care Med. 187:7 (2013), 703–714.
-
(2013)
Am. J. Resp. Crit. Care Med.
, vol.187
, Issue.7
, pp. 703-714
-
-
Dagouassat, M.1
Gagliolo, J.M.2
Chrusciel, S.3
Bourin, M.C.4
Duprez, C.5
Caramelle, P.6
Boyer, L.7
Hue, S.8
Stern, J.B.9
Validire, P.10
Longrois, D.11
Norel, X.12
Dubois-Rande, J.L.13
Le Gouvello, S.14
Adnot, S.15
Boczkowski, J.16
-
126
-
-
84940767877
-
Prostanoids as anti-inflammatory therapy: separating the good from the bad
-
Knox, A.J., Prostanoids as anti-inflammatory therapy: separating the good from the bad. Thorax 70:8 (2015), 711–712.
-
(2015)
Thorax
, vol.70
, Issue.8
, pp. 711-712
-
-
Knox, A.J.1
-
127
-
-
0034530199
-
Tumor necrosis factor-alpha-induced secretion of RANTES and interleukin-6 from human airway smooth-muscle cells. Modulation by cyclic adenosine monophosphate
-
Ammit, A.J., Hoffman, R.K., Amrani, Y., Lazaar, A.L., Hay, D.W., Torphy, T.J., Penn, R.B., Panettieri, R.A. Jr., Tumor necrosis factor-alpha-induced secretion of RANTES and interleukin-6 from human airway smooth-muscle cells. Modulation by cyclic adenosine monophosphate. Am. J. Resp. Cell and Mol. Biol. 23:6 (2000), 794–802.
-
(2000)
Am. J. Resp. Cell and Mol. Biol.
, vol.23
, Issue.6
, pp. 794-802
-
-
Ammit, A.J.1
Hoffman, R.K.2
Amrani, Y.3
Lazaar, A.L.4
Hay, D.W.5
Torphy, T.J.6
Penn, R.B.7
Panettieri, R.A.8
-
128
-
-
0034746479
-
Effects of prostaglandin E2 and cAMP elevating drugs on GM-CSF release by cultured human airway smooth muscle cells. Relevance to asthma therapy
-
Lazzeri, N., Belvisi, M.G., Patel, H.J., Yacoub, M.H., Chung, K.F., Mitchell, J.A., Effects of prostaglandin E2 and cAMP elevating drugs on GM-CSF release by cultured human airway smooth muscle cells. Relevance to asthma therapy. Am. J. Resp. Cell and Mol. Biol. 24:1 (2001), 44–48.
-
(2001)
Am. J. Resp. Cell and Mol. Biol.
, vol.24
, Issue.1
, pp. 44-48
-
-
Lazzeri, N.1
Belvisi, M.G.2
Patel, H.J.3
Yacoub, M.H.4
Chung, K.F.5
Mitchell, J.A.6
-
129
-
-
2342646152
-
Identification in human airways smooth muscle cells of the prostanoid receptor and signalling pathway through which PGE2 inhibits the release of GM-CSF
-
Clarke, D.L., Belvisi, M.G., Catley, M.C., Yacoub, M.H., Newton, R., Giembycz, M.A., Identification in human airways smooth muscle cells of the prostanoid receptor and signalling pathway through which PGE2 inhibits the release of GM-CSF. Br. J. Pharmacol. 141:7 (2004), 1141–1150.
-
(2004)
Br. J. Pharmacol.
, vol.141
, Issue.7
, pp. 1141-1150
-
-
Clarke, D.L.1
Belvisi, M.G.2
Catley, M.C.3
Yacoub, M.H.4
Newton, R.5
Giembycz, M.A.6
-
130
-
-
37349117437
-
Long-acting beta2-adrenoceptor agonists synergistically enhance glucocorticoid-dependent transcription in human airway epithelial and smooth muscle cells
-
Kaur, M., Chivers, J.E., Giembycz, M.A., Newton, R., Long-acting beta2-adrenoceptor agonists synergistically enhance glucocorticoid-dependent transcription in human airway epithelial and smooth muscle cells. Mol. Pharmacol. 73:1 (2008), 203–214.
-
(2008)
Mol. Pharmacol.
, vol.73
, Issue.1
, pp. 203-214
-
-
Kaur, M.1
Chivers, J.E.2
Giembycz, M.A.3
Newton, R.4
-
131
-
-
84873159987
-
cAMP regulation of airway smooth muscle function
-
Billington, C.K., Ojo, O.O., Penn, R.B., Ito, S., cAMP regulation of airway smooth muscle function. Pulm. Pharmacol. Ther. 26:1 (2013), 112–120.
-
(2013)
Pulm. Pharmacol. Ther.
, vol.26
, Issue.1
, pp. 112-120
-
-
Billington, C.K.1
Ojo, O.O.2
Penn, R.B.3
Ito, S.4
-
132
-
-
0036009461
-
Tumor necrosis factor-alpha-induced secretion of RANTES and interleukin-6 from human airway smooth muscle cells: modulation by glucocorticoids and beta-agonists
-
Ammit, A.J., Lazaar, A.L., Irani, C., O'Neill, G.M., Gordon, N.D., Amrani, Y., Penn, R.B., Panettieri, R.A. Jr., Tumor necrosis factor-alpha-induced secretion of RANTES and interleukin-6 from human airway smooth muscle cells: modulation by glucocorticoids and beta-agonists. Am. J. Resp. Cell and Mol. Biol. 26:4 (2002), 465–474.
-
(2002)
Am. J. Resp. Cell and Mol. Biol.
, vol.26
, Issue.4
, pp. 465-474
-
-
Ammit, A.J.1
Lazaar, A.L.2
Irani, C.3
O'Neill, G.M.4
Gordon, N.D.5
Amrani, Y.6
Penn, R.B.7
Panettieri, R.A.8
-
133
-
-
84875330999
-
Long-acting beta2-agonists increase fluticasone propionate-induced mitogen-activated protein kinase phosphatase 1 (MKP-1) in airway smooth muscle cells
-
Manetsch, M., Rahman, M.M., Patel, B.S., Ramsay, E.E., Rumzhum, N.N., Alkhouri, H., Ge, Q., Ammit, A.J., Long-acting beta2-agonists increase fluticasone propionate-induced mitogen-activated protein kinase phosphatase 1 (MKP-1) in airway smooth muscle cells. PLoS One, 8(3), 2013, e59635.
-
(2013)
PLoS One
, vol.8
, Issue.3
-
-
Manetsch, M.1
Rahman, M.M.2
Patel, B.S.3
Ramsay, E.E.4
Rumzhum, N.N.5
Alkhouri, H.6
Ge, Q.7
Ammit, A.J.8
-
134
-
-
84864507046
-
Sphingosine 1-phosphate induces MKP-1 expression via p38 MAPK- and CREB-mediated pathways in airway smooth muscle cells
-
Che, W., Manetsch, M., Quante, T., Rahman, M.M., Patel, B.S., Ge, Q., Ammit, A.J., Sphingosine 1-phosphate induces MKP-1 expression via p38 MAPK- and CREB-mediated pathways in airway smooth muscle cells. Biochimica et biophysica acta 1823:10 (2012), 1658–1665.
-
(2012)
Biochimica et biophysica acta
, vol.1823
, Issue.10
, pp. 1658-1665
-
-
Che, W.1
Manetsch, M.2
Quante, T.3
Rahman, M.M.4
Patel, B.S.5
Ge, Q.6
Ammit, A.J.7
-
135
-
-
84863709901
-
Corticosteroids and beta(2)-agonists upregulate mitogen-activated protein kinase phosphatase 1: in vitro mechanisms
-
Manetsch, M., Ramsay, E.E., King, E.M., Seidel, P., Che, W., Ge, Q., Hibbs, D.E., Newton, R., Ammit, A.J., Corticosteroids and beta(2)-agonists upregulate mitogen-activated protein kinase phosphatase 1: in vitro mechanisms. Br. J. Pharmacol. 166:7 (2012), 2049–2059.
-
(2012)
Br. J. Pharmacol.
, vol.166
, Issue.7
, pp. 2049-2059
-
-
Manetsch, M.1
Ramsay, E.E.2
King, E.M.3
Seidel, P.4
Che, W.5
Ge, Q.6
Hibbs, D.E.7
Newton, R.8
Ammit, A.J.9
-
136
-
-
84929466885
-
Inhibitors of phosphodiesterase 4, but not phosphodiesterase 3, increase beta2-agonist-induced expression of antiinflammatory mitogen-activated protein kinase phosphatase 1 in airway smooth muscle cells
-
Patel, B.S., Prabhala, P., Oliver, B.G., Ammit, A.J., Inhibitors of phosphodiesterase 4, but not phosphodiesterase 3, increase beta2-agonist-induced expression of antiinflammatory mitogen-activated protein kinase phosphatase 1 in airway smooth muscle cells. Am. J. Resp. Cell and Mol. Biol. 52:5 (2015), 634–640.
-
(2015)
Am. J. Resp. Cell and Mol. Biol.
, vol.52
, Issue.5
, pp. 634-640
-
-
Patel, B.S.1
Prabhala, P.2
Oliver, B.G.3
Ammit, A.J.4
-
137
-
-
85017386748
-
Roflumilast N-Oxide in combination with formoterol enhances the antiinflammatory effect of dexamethasone in airway smooth muscle cells
-
Patel, B.S., Rahman, M.M., Baehring, G., Xenaki, D., Tang, F.S., Oliver, B.G., Ammit, A.J., Roflumilast N-Oxide in combination with formoterol enhances the antiinflammatory effect of dexamethasone in airway smooth muscle cells. Am. J. Resp. Cell and Mol. Biol. 56:4 (2017), 532–538.
-
(2017)
Am. J. Resp. Cell and Mol. Biol.
, vol.56
, Issue.4
, pp. 532-538
-
-
Patel, B.S.1
Rahman, M.M.2
Baehring, G.3
Xenaki, D.4
Tang, F.S.5
Oliver, B.G.6
Ammit, A.J.7
-
138
-
-
84964556426
-
Prostaglandin E2 induces expression of MAPK phosphatase 1 (MKP-1) in airway smooth muscle cells
-
Rumzhum, N.N., Ammit, A.J., Prostaglandin E2 induces expression of MAPK phosphatase 1 (MKP-1) in airway smooth muscle cells. Euro. J. Pharmacol. 782 (2016), 1–5.
-
(2016)
Euro. J. Pharmacol.
, vol.782
, pp. 1-5
-
-
Rumzhum, N.N.1
Ammit, A.J.2
-
139
-
-
84990175796
-
The anti-inflammatory effects of PGE2 on human lung macrophages are mediated by the EP4 receptor
-
Gill, S.K., Yao, Y., Kay, L.J., Bewley, M.A., Marriott, H.M., Peachell, P.T., The anti-inflammatory effects of PGE2 on human lung macrophages are mediated by the EP4 receptor. Br. J. Pharmacol. 173:21 (2016), 3099–3109.
-
(2016)
Br. J. Pharmacol.
, vol.173
, Issue.21
, pp. 3099-3109
-
-
Gill, S.K.1
Yao, Y.2
Kay, L.J.3
Bewley, M.A.4
Marriott, H.M.5
Peachell, P.T.6
-
140
-
-
84940462312
-
Activation of EP receptors prevents endotoxin-induced neutrophil infiltration into the airways and enhances microvascular barrier function
-
Konya, V., Maric, J., Jandl, K., Luschnig, P., Aringer, I., Lanz, I., Platzer, W., Theiler, A., Barnthaler, T., Frei, R., Marsche, G., Marsh, L.M., Olschewski, A., Lippe, I.T., Heinemann, A., Schuligoi, R., Activation of EP receptors prevents endotoxin-induced neutrophil infiltration into the airways and enhances microvascular barrier function. Br. J. Pharmacol. 172:18 (September 2015), 4454–4468.
-
(2015)
Br. J. Pharmacol.
, vol.172
, Issue.18
, pp. 4454-4468
-
-
Konya, V.1
Maric, J.2
Jandl, K.3
Luschnig, P.4
Aringer, I.5
Lanz, I.6
Platzer, W.7
Theiler, A.8
Barnthaler, T.9
Frei, R.10
Marsche, G.11
Marsh, L.M.12
Olschewski, A.13
Lippe, I.T.14
Heinemann, A.15
Schuligoi, R.16
|